Development of imaging and therapeutic strategies for ophthalmology, vascular medicine, and oncology
The main objectives of Dr. Jayagopal's research are to develop disease-specific imaging and drug delivery agents, and to identify molecular targets accessible by these agents for clinical applications in ophthalmology, oncology, and vascular medicine. The laboratory primarily utilizes nanotechnology-based approaches to interface drugs and/or imaging agents with diseased cells and tissues.
Current projects include:
- Nanoscale engineering of imaging and drug delivery carriers for improved functional capabilities
- Improved targeting and efficacy of gene therapy strategies
- Development of intracellular targeting strategies for imaging and drug delivery
- Molecular imaging of the retina using optical imaging agents